Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Challenges of traditional UAT, key benefits of embedded UAT, and creating a collaborative and efficient eCOA.
April 26, 2022
By: Kris Gustafson
Vice President and Global Head IQVIA eCOA
Electronic Clinical Outcomes Assessments (eCOAs) have become a cornerstone of digital clinical trials due to the critical role they play in collecting accurate and timely data from patients throughout the developmental stages of a clinical trial. They are also valuable for their ability to be implemented to capture patient reported data, giving sponsors almost instant access to trends across the trial. The advancement of this technology is pivotal, as the sooner a trial is up and running, the sooner sponsors can recruit patients, collect data, and advance to market approval. User acceptance testing (UAT) is a crucial process to validate that the eCOA has been designed to optimize the patient experience, meet the needs of the protocol, and deliver the insights needed to complete the trial. However, with the pressure to continue to improve trial efficiencies, the traditional approach to conducting UAT only after the eCOA design process is complete can lead to unforeseen setbacks if major changes need to be made to the eCOAs. This can be avoided by conducting UAT in parallel with the eCOA being built, to ensure full alignment of the functionality and design within the assessment. Challenges of traditional UAT At the start of implementing an eCOA, study teams work to draft a set of specifications envisioning the format and function of the assessment. The process from design to implementation has traditionally taken weeks to months, and sponsors are often unable to preview the eCOA until the end of that period. UAT, now more vital than ever in the age of patient centricity, is a step that often must be pushed out until design is complete. And if it doesn’t go well, sponsors are left to tear apart their hard work and go back to the drawing board with the user feedback in mind. As much of the clinical research landscape undergoes massive digital transformation, this is an area that can and should evolve to improve efficiency and patient experience. With recent advances in technology capabilities further expedited by COVID-19, sponsors now have the ability to consider taking steps to evolve their eCOA and UAT processes to design, build, and preview an assessment all in parallel rather than succession. Key benefits of embedded UAT UAT is a critical part of any software development project process to ensure that the end user is satisfied with the finished product and that the product meets the business requirements. This is especially the case in the eCOA design process since time is of the essence when you are launching a study and going back and forth with researchers to gather requirements, program, test, and deploy takes unnecessary time. It is to the advantage of both the sponsor and development team to take an embedded approach to UAT. There are Key benefits include: · Efficiency: Beginning UAT at the onset of the eCOA process can make the development process faster and shave weeks off start time. Creating and validating an eCOA from scratch for each study can be a lengthy process that can add months to the trial planning process, and even small errors can lead to setbacks. Embedding UAT upfront in the process is a faster and more efficient method that results in a high quality eCOA that meets the exact needs of our clients and ultimately patients. · Collaboration: When leveraging real-time, embedded UAT, there is no need to have multiple rounds of back-and-forth feedback. It creates the opportunity for transparency and a fully collaborative process that makes the user a primary participant in the design process. · Cost-effectiveness: With an eCOA development process that is easier and less stressful for developers and sponsors, it can make the development process faster and less costly while mitigating any potential risks. Like any development project, the most expensive time to fix problems is at the end. When an assessment needs to be redesigned in response to UAT, it creates added development cycles and expense. Creating a collaborative and efficient eCOA As sponsors feel the heat to make their trials more adaptive and efficient, UAT will need to be an embedded part of the design process rather than an afterthought, and with the right technology, the traditional approach will fall by the wayside. Looking forward, the benefits of executing UAT while designing an eCOA will become the new industry standard. By incorporating an agile development process with embedded UAT, sponsors and researchers can collaborate in real time, creating efficiency, transparency, and keeping trials moving forward toward eventual approval.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !